HARP News and Press, Harpoon Therapeutics Inc. From 10/23/23

2023-10-23 13:20:00 ET Summary Chevron to buy Hess in an all-stock transaction for $53 billion. The 10-year Treasury yield briefly crosses 5% for the first time since 2007. Jefferies comes out with its USA Equity Strategy report and allocation recommendations. Listen...

2023-10-23 10:00:15 ET Health Care Select Sector Fund ETF: Riding The Healthcare Boom Stocks to watch in the Health Care sector as earnings close in For further details see: ImmunityBio, Palatin Technologies among healthcare movers

2023-10-23 07:52:10 ET DENVER, Colo., Oct 23, 2023 ( www.247marketnews.com )- Harpoon Therapeutics, Inc. (NASDAQ: HARP) stated, this morning, that it entered into a securities purchase agreement for a private placement in public equity (“PIPE”) financing, led by a leading ...

SOUTH SAN FRANCISCO, Calif., Oct. 23, 2023 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (NASDAQ: HARP) (the “Company”), a clinical-stage immunotherapy company developing novel T cell engagers, today announced that it has entered into a securities purchase agreement for a priv...

2023-10-23 06:36:59 ET More on Harpoon Biggest stock movers today: Crypto-focused stocks, Roivant Sciences and more Seeking Alpha’s Quant Rating on Harpoon Therapeutics Historical earnings data for Harpoon Therapeutics Financial information for Harpoon...

2023-10-23 05:32:56 ET Stock futures fell slightly in premarket trading on Monday as U.S. Treasury yields remained near multiyear highs amid investor concerns about rising interest rates ahead of big tech earnings reports. For further details see: Biggest stock movers today: Crypto-...

Confirmed response rate 35% (11/31), across all tumor types and patient cohorts treated with 1 mg priming dose, including three confirmed, complete responses 32% (6/19) confirmed response rate in patients with small cell lung cancer (SCLC), including one confirmed complete response ...

Harpoon Therapeutics, Inc. (NASDAQ: HARP) is one of today's top gainers. The company's shares are currently up 18.5% on the day to $6.34. Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of...

SOUTH SAN FRANCISCO, Calif., Oct. 16, 2023 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (Nasdaq: HARP), a clinical-stage immunotherapy company developing novel T cell engagers, today announced that it will host a live webcast at 8:00 a.m. ET / 2:00 p.m. CEST on Monday, October 23, 2023 to ...

2023-10-13 13:36:57 ET Gainers: Sigma Additive Solutions ( SASI ) +138% . P & F Industries ( PFIN ) +87% . Bio-Path Holdings ( BPTH ) +61% . MicroAlgo ( MLGO ) +31% . Comtech Telecommunications Corp. ( CMTL ) +29% . PSQ H...